VIVUS gaps up after addition to U.S. 1 List at BofA/Merrill, levels to watch The stock is up nearly 11% at time of writing, gapping up above recent range trading highs and the stock's 10-day moving average. At the current price of $15.30, next resistance is at $15.50, and then at $16.38. Support is at $14.71.
News For VVUS From The Last 14 Days
Check below for free stories on VVUS the last two weeks.
On The Fly: Analyst Downgrade Summary Today's noteworthy downgrades include: AVG Technologies (AVG) downgraded to Neutral from Buy at Goldman... Cigna (CI) downgraded to Hold from Buy at Jefferies... Cree (CREE) downgraded to Neutral from Buy at Sterne Agee... Melco Crown (MPEL) downgraded to Neutral from Buy at UBS... SolarCity (SCTY) downgraded to Neutral from Buy at Roth Capital... KB Home (KBH) downgraded to Market Perform from Outperform at Raymond James... Ryland Group (RYL) downgraded to Underperform from Market Perform at Raymond James... Alere (ALR) downgraded to Hold from Buy at Craig-Hallum... Evolution Petroleum (EPM) downgraded to Hold from Buy at MLV Equity... Oil States (OIS) downgraded to Hold from Buy at BB&T... VIVUS (VVUS) downgraded to Neutral from Buy at Lazard Capital.
Subscribe for More Information